Literature DB >> 6804607

Neostigmine myopathy is a calcium ion-mediated myopathy initially affecting the motor end-plate.

M Kawabuchi.   

Abstract

Morphological techniques were used to determine the acute and chronic effects of neostigmine on rat muscles. Transient calcium deposits, eliminated by prior treatment of sections with ethyleneglycol bis (aminoethylether) tetracetate (EGTA), were independent of fiber type and found at sites corresponding to neostigmine-induced focal lesions. The dimension and number of focal lesions and calcium deposits gradually decreased with chronic drug treatment. Size, shape, and density of the calcium deposits varied. Alterations in the motor nerve terminal, synaptic space, and junctional fold persisted even when banding patterns at the motor end plates were intact. Characteristic intermediate findings consisted of rod bodies and ribosomal clusters. Such clusters were frequently mingled and clumped sarcoplasmic reticulums, T-systems, or mitochondria. Despite continued administration of neostigmine, focal myopathic changes, other than in the synaptic region of the end plates, were reversible.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804607     DOI: 10.1097/00005072-198205000-00005

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Chronic progressive and relapsing neuromyopathy with massive dilatations of endoplasmic reticulum in muscle fibers.

Authors:  B Lach; S Christie; D Preston
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Morphogenesis of nuclear inclusions in the soleplate region of rat skeletal muscle fibers following chronic daily administration of neostigmine.

Authors:  M Kawabuchi; M Osame; T Kanaseki
Journal:  Cell Tissue Res       Date:  1989-04       Impact factor: 5.249

3.  Skeletal muscle IP3R1 receptors amplify physiological and pathological synaptic calcium signals.

Authors:  Haipeng Zhu; Bula J Bhattacharyya; Hong Lin; Christopher M Gomez
Journal:  J Neurosci       Date:  2011-10-26       Impact factor: 6.167

4.  Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.

Authors:  C M Gomez; R Maselli; J E Gundeck; M Chao; J W Day; S Tamamizu; J A Lasalde; M McNamee; R L Wollmann
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

5.  Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome.

Authors:  Haipeng Zhu; Gary E Grajales-Reyes; Vivianette Alicea-Vázquez; Jose G Grajales-Reyes; KaReisha Robinson; Peter Pytel; Carlos A Báez-Pagán; Jose A Lasalde-Dominicci; Christopher M Gomez
Journal:  Exp Neurol       Date:  2014-10-23       Impact factor: 5.330

6.  Functional effects of nemaline myopathy mutations on human skeletal alpha-actin.

Authors:  Becky M Miller; Kathleen M Trybus
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

7.  Acute toxicity of pyridostigmine in rats: histological findings.

Authors:  J O Gebbers; M Lötscher; W Kobel; R Portmann; J A Laissue
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.